← Open Payments lookup

CATHY DAVIS: Open Payments

NPI 1891152906 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$912 in 33 payments from 9 companies in 2025. Trend: 2023 $1,803 · 2024 $1,399 · 2025 $912

Food & beverage: $912
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.9$243
Otsuka America Pharmaceutical, Inc.5$241
Teva Pharmaceuticals USA, Inc.6$189
Alkermes, Inc.4$78
Lundbeck LLC3$54
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Janssen Pharmaceuticals, Inc2$35
Luye Pharma (USA) Ltd.1$21
E.R. Squibb & Sons, L.L.C.1$15

Products named: INGREZZA, ABILIFY MAINTENA, AUSTEDO XR, ABILIFY ASIMTUFII, VIVITROL, CAPLYTA, INVEGA SUSTENNA, UZEDY.

Industry payments across LA — which companies pay providers there.